Original articleDrug-related chromosomal changes in chemoresistant human ovarian carcinoma cells
References (39)
- et al.
Genetic transformation of murine bone marrow cells to methotrexate resistance
Blood
(1983) - et al.
Recurring sites of chromosome change in human ovarian carcinoma
- et al.
The relationship of tumorigenicity to multidrug (MDR) resistance in human and experimental cancers
- et al.
Cytogenetic and molecular genetic alterations associated with the development of anthracycline resistance
- et al.
Drug resistance in medical oncology
Neth J Med
(1987) - et al.
Clinical aspects of drug resistance
Cancer Surv
(1986) The oncologic end game
J Clin Oncol
(1986)- et al.
The genetic origin of drug resistance in neoplasms: implications for systemic therapy
Cancer Res
(1984) - et al.
Genetic instability in the development of drug resistance
Semin Oncol
(1985) - et al.
Tumor heterogeneity and drug resistance
J Clin Oncol
(1986)
Gene amplification, drug resistance, and cancer
Cancer Res
(1984)
Methotrexate resistance and gene amplification. Mechanisms and implications
Cancer
(1986)
Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines
Nature
(1985)
Cytologic evidence for gene amplification in methotrexate-resistant cells obtained from a patient with ovarian adenocarcinoma
J Clin Oncol
(1984)
Incidence of double minutes, cytogenetic equivalents of gene amplification, in human carcinoma cells
Int J Cancer
(1984)
Multiple-drug resistance in human cancer
N Engl J Med
(1987)
Chromosomes studies
Characterization of a human ovarian adenocarcinoma line, IGROV1, in tissue culture and nude mice
Cancer Res
(1985)
Sur une nouvelle technique d'analyse du caryotype humain
CR Acad Sci Paris
(1971)
Cited by (18)
3D mapping of individual cells using a proton microbeam
1999, Nuclear Instruments and Methods in Physics Research, Section B: Beam Interactions with Materials and AtomsNuclear microprobe analysis of iodine and iron distributions in tumor cells exposed to the anthracycline 4′-iodo-4′-deoxydoxorubicin
1997, Nuclear Instruments and Methods in Physics Research, Section B: Beam Interactions with Materials and AtomsA multidrug-resistant ovarian carcinoma cell line with a malignant suppressed phenotype is a CD44 gene expression defective mutant
1992, Cancer Genetics and CytogeneticsAntigenic properties associated with vinca alkaloid resistance in ovarian cancer cells: identification of a 92,000 DA protein
1991, Biochemical and Biophysical Research CommunicationsHigh-pressure intrapleural chemotherapy: Feasibility in the pig model
2012, World Journal of Surgical Oncology
Copyright © 1989 Published by Elsevier Inc.